Successful Treatment of Hereditary Hemorrhagic Telangiectasia with Octreotide
Recommended Citation
Houghton KD, Umar B, and Schairer J. Successful Treatment of Hereditary Hemorrhagic Telangiectasia with Octreotide. ACG Case Rep J 2019; 6(6).
Document Type
Article
Publication Date
2019
Publication Title
ACG Case Rep J
Abstract
Hereditary hemorrhagic telangiectasia (HHT) is a disorder characterized by telangiectasias and arteriovenous malformations. We present a case report of a 74-year-old man diagnosed with HHT having a favorable response to a somatostatin analogue for treatment. This patient had been suffering from chronic anemia from recurrent gastrointestinal bleeding, requiring oral/intravenous iron replacement, frequent endoscopic ablations, and blood transfusions. Due to insufficient treatment, he was started on subcutaneous octreotide, with significant improvement as evidenced by a steady increase in the hemoglobin level, decreased endoscopic interventions, and decreased blood transfusions, making this the first case of HHT successfully treated with octreotide.
PubMed ID
31616764
Volume
6
Issue
6
